OMB redefines agency Chief AI Officers as adoption advocates and risk advisers

One officer at each agency now holds three jobs at once: advocate for adoption, classifier of risk, adviser on AI spending ^[3][4][14]. For a vendor that turns a compliance problem into a sales problem. Land on the lower-risk side and the product inherits the accountability chain the agency already runs for its IT ^[6]; land in the high-impact category and it inherits heightened due diligence whose steps the fact sheet does not set out ^[5][17].

How unsettled the sort is shows in the White House's own illustrative list: four uses across three agencies, two of them at Veterans Affairs, where AI standardises patient care and flags pulmonary nodules during lung cancer screening, one at Justice analysing the global drug market for trafficking investigations, and one at NASA navigating the Mars 2020 rover ^[13][15]. The document places none of the four in either category ^[17], and screening support in oncology sits close enough to safety that a clinical vendor should treat the classification as a live question rather than a formality.

The phrase "American AI" appears five times in the fact sheet, which never says what makes AI American ^[16]. Corporate domicile of the seller, ownership of the weights, where the training compute ran, whose paper the reseller holds: each reading admits a different set of bidders, and the pairing of a competitive marketplace with maximised American use does not choose between them ^[10][11].

Read as acceleration, the package lowers an agency's cost of trying a supplier, which tends to produce more pilots at smaller sizes rather than fewer large awards ^[8][9]. Read as risk triage, or rather the version that matters to the biggest programmes, heightened due diligence for high-impact systems may run slower than the approvals it replaced, and rights and safety are exactly where the large agency caseloads sit ^[5]. Agencies are also to produce an AI adoption maturity assessment, and the fact sheet attaches no date to it ^[7][17]. What would settle the question is the memo text rather than the summary of it: if M-25-21's high-impact procedures take longer than what they replace, or if the existing IT accountability chain proves to be the slower gate, the change is one of venue and not of pace ^[6][17]. Until then, the qualifying bar for selling into the Executive Branch is one officer's classification, and the White House has told that officer to say yes to the lower-risk half ^[4][12].